Alex Therapeutics

Alex Therapeutics is a digital therapeutics company responsible for designing and developing Software as a Medical Device (SaMD). By combining Cognitive Behavioral Therapy (CBT) and Acceptance and Commitment Therapy (ACT) with artificial intelligence, it provides highly personalized and effective care to patients. Its first product, Alex AI-Smoking Cessation, integrates CBT with AI to help patients treat nicotine addiction. So far, more than 100,000 patients have chosen Alex to help them overcome nicotine addiction.The Alex platform allows for the easy development of new products, and we see tremendous potential in future verticals such as obesity, depression, oncology, and more.